GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Eutilex Co Ltd (XKRX:263050) » Definitions » Insider Ownership

Eutilex Co (XKRX:263050) Insider Ownership : 0.00 % (As of May. 14, 2025)


View and export this data going back to 2018. Start your Free Trial

What is Eutilex Co Insider Ownership?

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Eutilex Co's insider ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Eutilex Co's Institutional Ownership is 0.10%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Eutilex Co's Float Percentage Of Total Shares Outstanding is 0.00%.


Eutilex Co Insider Ownership Historical Data

The historical data trend for Eutilex Co's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eutilex Co Insider Ownership Chart

Eutilex Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Insider Ownership
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Eutilex Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Insider Ownership Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Eutilex Co Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.


Eutilex Co Business Description

Traded in Other Exchanges
N/A
Address
Daeryung Technotown 17, Suite 1401, Gasan Digital 1-ro 25, Geumcheon-gu, Seoul, KOR, 08594
Eutilex Co Ltd is a Korean that operates in the anti-tumor immunotherapy market. The company develops anti-tumor T cell therapy and antibody therapeutics based on its immunotherapy technology. Its pipeline products include T Cell Therapy (4-1BB CTL), CAR-T, and Antibody.

Eutilex Co Headlines

No Headlines